In conclusion, despite the deleterious effect of aging in CML prognosis, our results showing that activating NK cell receptors can be expressed both in middle-aged and elderly TKI-treated CML patients highlight the interest to extensively analyse the effect of aging on NK cell phenotype and function in these patients. Here, KLRD1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.